|
US670A
(en)
|
|
1838-04-02 |
|
Improved mode of forming raised surfaces for printing on paper, calico |
|
US6033A
(en)
|
|
1849-01-16 |
|
Clapboard-machine |
|
US692956A
(en)
|
1900-04-30 |
1902-02-11 |
Daniel Aaron Williamson |
Shoe-lacing machine.
|
|
US4394448A
(en)
|
1978-02-24 |
1983-07-19 |
Szoka Jr Francis C |
Method of inserting DNA into living cells
|
|
US4769331A
(en)
|
1981-09-16 |
1988-09-06 |
University Patents, Inc. |
Recombinant methods and materials
|
|
US5505941A
(en)
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
US5174993A
(en)
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
|
US5833975A
(en)
|
1989-03-08 |
1998-11-10 |
Virogenetics Corporation |
Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
|
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
US5338683A
(en)
|
1981-12-24 |
1994-08-16 |
Health Research Incorporated |
Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
|
|
US5110587A
(en)
|
1981-12-24 |
1992-05-05 |
Health Research, Incorporated |
Immunogenic composition comprising synthetically modified vaccinia virus
|
|
US4745051A
(en)
|
1983-05-27 |
1988-05-17 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
|
DE3584341D1
(de)
|
1984-08-24 |
1991-11-14 |
Upjohn Co |
Rekombinante dna-verbindungen und expression von polypeptiden wie tpa.
|
|
US4945050A
(en)
|
1984-11-13 |
1990-07-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
US4963481A
(en)
|
1985-12-18 |
1990-10-16 |
Genetics Institute Inc |
Promoter system
|
|
US4968615A
(en)
|
1985-12-18 |
1990-11-06 |
Ciba-Geigy Corporation |
Deoxyribonucleic acid segment from a virus
|
|
ZA874681B
(en)
|
1986-07-01 |
1988-04-27 |
Genetics Inst |
Novel osteoinductive factors
|
|
EP0260148A3
(en)
|
1986-09-12 |
1989-06-07 |
Genentech, Inc. |
Improved recombinant expression method, vector and transformed cells
|
|
IL84154A0
(en)
|
1986-10-16 |
1988-03-31 |
Microgenesys Inc |
Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
DE3743138A1
(de)
|
1987-12-18 |
1989-09-14 |
Mayr Christian Gmbh & Co Kg |
Schleifringlose, elektromagnetische ueberlastkupplung
|
|
WO1990001543A1
(fr)
|
1988-07-29 |
1990-02-22 |
Intracel Corporation |
Procede d'expression genetique de proteines heterologues par des cellules transfectees in vivo
|
|
CA2003300A1
(en)
|
1988-11-21 |
1990-05-21 |
Franklin Volvovitz |
Skin test and test kit for aids
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5552143A
(en)
|
1989-03-24 |
1996-09-03 |
The Wistar Institute Of Anatomy & Biology |
Recombinant cytomegalovirus vaccine
|
|
US5591439A
(en)
|
1989-03-24 |
1997-01-07 |
The Wistar Institute Of Anatomy And Biology |
Recombinant cytomegalovirus vaccine
|
|
GB9001766D0
(en)
|
1990-01-25 |
1990-03-28 |
Univ Court Of The University O |
Vaccines
|
|
US5514375A
(en)
|
1990-08-15 |
1996-05-07 |
Virogenetics Corporation |
Flavivirus recombinant poxvirus vaccine
|
|
MY109299A
(en)
|
1990-08-15 |
1996-12-31 |
Virogenetics Corp |
Recombinant pox virus encoding flaviviral structural proteins
|
|
DK0643767T3
(da)
*
|
1990-10-18 |
1999-04-26 |
Stryker Corp |
Osteogene peptider
|
|
AU672359B2
(en)
|
1991-03-07 |
1996-10-03 |
Virogenetics Corporation |
Genetically engineered vaccine strain
|
|
US5843456A
(en)
|
1991-03-07 |
1998-12-01 |
Virogenetics Corporation |
Alvac poxvirus-rabies compositions and combination compositions and uses
|
|
US5997878A
(en)
|
1991-03-07 |
1999-12-07 |
Connaught Laboratories |
Recombinant poxvirus-cytomegalovirus, compositions and uses
|
|
US5652337A
(en)
*
|
1991-03-11 |
1997-07-29 |
Creative Biomolecules, Inc. |
OP-3-induced morphogenesis
|
|
US5382425A
(en)
|
1992-01-13 |
1995-01-17 |
Syntro Corporation |
Recombinant swinepox virus
|
|
US5846945A
(en)
|
1993-02-16 |
1998-12-08 |
Onyx Pharmaceuticals, Inc. |
Cytopathic viruses for therapy and prophylaxis of neoplasia
|
|
US6133028A
(en)
|
1993-05-28 |
2000-10-17 |
Transgene S.A. |
Defective adenoviruses and corresponding complementation lines
|
|
US6485729B1
(en)
|
1993-09-13 |
2002-11-26 |
Protein Sciences Corporation |
Neuraminidase-supplemented compositions
|
|
FR2712603B1
(fr)
|
1993-11-18 |
1996-02-09 |
Centre Nat Rech Scient |
Virus recombinants, préparation et utilisation en thérapie génique.
|
|
US5529780A
(en)
|
1994-03-30 |
1996-06-25 |
Virogenetics Corporation |
Nucleotide and amino acid sequences of canine herpesvirus gB and gC
|
|
FR2728795B1
(fr)
|
1994-12-30 |
1997-03-21 |
Rhone Merieux |
Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
|
|
EP0826063A1
(en)
|
1995-04-25 |
1998-03-04 |
Vical Incorporated |
Single-vial formulations of dna/lipid complexes
|
|
JPH0946509A
(ja)
|
1995-07-28 |
1997-02-14 |
Minolta Co Ltd |
ディジタル複写機
|
|
FR2741806B1
(fr)
|
1995-11-30 |
1998-02-20 |
Rhone Merieux |
Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
|
|
US6498142B1
(en)
|
1996-05-06 |
2002-12-24 |
Curis, Inc. |
Morphogen treatment for chronic renal failure
|
|
FR2750865B1
(fr)
|
1996-06-27 |
1998-12-04 |
Rhone Merieux |
Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2
|
|
FR2750866B1
(fr)
|
1996-06-27 |
1998-11-27 |
Rhone Merieux |
Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
|
|
US6090393A
(en)
|
1996-07-03 |
2000-07-18 |
Merial |
Recombinant canine adenoviruses, method for making and uses thereof
|
|
AU737243B2
(en)
|
1996-07-03 |
2001-08-16 |
Merial, Inc. |
Recombinant canine adenovirus (CAV) containing exogenous DNA
|
|
US6156567A
(en)
|
1996-07-03 |
2000-12-05 |
Merial |
Truncated transcriptionally active cytomegalovirus promoters
|
|
FR2751224B1
(fr)
|
1996-07-19 |
1998-11-20 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
|
|
FR2751227B1
(fr)
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
|
|
FR2751228B1
(fr)
|
1996-07-19 |
1998-11-20 |
Rhone Merieux |
Vaccin polynucleotidique bovin pour voie intradermique
|
|
FR2751223B1
(fr)
|
1996-07-19 |
1998-12-04 |
Rhone Merieux |
Formule de vaccin polynucleotidique felin
|
|
FR2751226B1
(fr)
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies du cheval
|
|
FR2751229B1
(fr)
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
|
|
FR2751225B1
(fr)
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique aviaire
|
|
ATE198910T1
(de)
|
1996-10-17 |
2001-02-15 |
Oxford Biomedica Ltd |
Retrovirale vektoren
|
|
FR2757061B1
(fr)
|
1996-12-16 |
1999-03-26 |
Rhone Merieux |
Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
|
|
FR2758986B1
(fr)
|
1997-01-31 |
1999-04-30 |
Rhone Merieux |
Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
|
|
US6183752B1
(en)
|
1997-02-05 |
2001-02-06 |
Pasteur Merieux Serums Et Vaccins |
Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
|
|
US6368603B1
(en)
|
1997-03-05 |
2002-04-09 |
Merial Limited |
Lyme combination compositions and uses
|
|
US6004777A
(en)
|
1997-03-12 |
1999-12-21 |
Virogenetics Corporation |
Vectors having enhanced expression, and methods of making and uses thereof
|
|
US5990091A
(en)
|
1997-03-12 |
1999-11-23 |
Virogenetics Corporation |
Vectors having enhanced expression, and methods of making and uses thereof
|
|
CA2289123A1
(en)
*
|
1997-05-05 |
1998-11-12 |
Creative Biomolecules, Inc. |
Therapies for acute renal failure
|
|
AU7473098A
(en)
*
|
1997-05-07 |
1998-11-27 |
Biogen, Inc. |
Novel therapies for cystic kidney disease
|
|
CA2294793A1
(fr)
|
1997-06-30 |
1999-01-14 |
Rhone-Poulenc Rorer S.A. |
Amelioration du transfert d'acide nucleique dans le muscle strie et combinaison permettant la mise en oeuvre du procede
|
|
CA2297375A1
(en)
|
1997-07-24 |
1999-02-04 |
Valentis, Inc. |
Ghrh expression system and methods of use
|
|
US6348450B1
(en)
|
1997-08-13 |
2002-02-19 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom and uses thereof
|
|
FR2781159B1
(fr)
|
1998-07-06 |
2000-10-06 |
Merial Sas |
Vaccin circovirus et parvovirus porcin
|
|
US6391314B1
(en)
|
1997-10-03 |
2002-05-21 |
Merial |
Porcine circoviruses vaccines diagnostic reagents
|
|
US6224882B1
(en)
|
1997-11-07 |
2001-05-01 |
Protein Science Corp. |
Insect cells or fractions as adjuvant for antigens
|
|
DK1895010T3
(da)
|
1997-12-22 |
2011-11-21 |
Oxford Biomedica Ltd |
Vektorer baseret på virus for infektiøs hesteanæmi (eiav)
|
|
US6294176B1
(en)
|
1998-07-10 |
2001-09-25 |
Schering-Plough Veterinary Corp. |
Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
|
|
US6103526A
(en)
|
1998-10-08 |
2000-08-15 |
Protein Sciences Corporation |
Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using
|
|
BR0001606A
(pt)
|
1999-04-12 |
2001-04-24 |
Pfizer Prod Inc |
Composições de hormÈnio de crescimento e de hormÈnio de liberação de hormÈnio de crescimento
|
|
US6497883B1
(en)
|
1999-06-10 |
2002-12-24 |
Merial |
Porcine circovirus recombinant poxvirus vaccine
|
|
FR2796397B1
(fr)
|
1999-07-16 |
2006-09-01 |
Merial Sas |
Genes de calicivirus felin et vaccins notamment vaccins recombines
|
|
WO2001054706A2
(en)
*
|
2000-01-31 |
2001-08-02 |
Uwe Waldemar Rothenpieler |
Method for treating kidney disorders
|
|
US20030224501A1
(en)
*
|
2000-03-17 |
2003-12-04 |
Young Paul E. |
Bone morphogenic protein polynucleotides, polypeptides, and antibodies
|
|
EP1203819A3
(en)
|
2000-10-06 |
2002-08-07 |
Transgene S.A. |
Anti-inflammatory vectors
|
|
EP1205551A1
(en)
|
2000-11-09 |
2002-05-15 |
Pfizer Products Inc. |
Growth hormone and growth hormone releasing hormone compositions
|
|
US20020173453A1
(en)
*
|
2000-12-15 |
2002-11-21 |
Rama Akella |
Method of treating renal injury
|
|
CA2449008A1
(en)
|
2001-06-01 |
2002-12-12 |
Wyeth |
Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
|
|
FR2829498B1
(fr)
|
2001-09-11 |
2003-11-28 |
Merial Sas |
Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins
|
|
CA2469310C
(en)
|
2001-12-11 |
2013-01-29 |
Advisys, Inc. |
Plasmid mediated supplementation for treating chronically ill subjects
|
|
JP2006516020A
(ja)
*
|
2002-08-28 |
2006-06-15 |
キュリス インコーポレイテッド |
慢性腎不全の治療におけるモルフォゲン及びace阻害薬の共投与
|
|
US7468273B2
(en)
*
|
2003-05-01 |
2008-12-23 |
Meial Limited |
Canine GHRH gene, polypeptides and methods of use
|
|
WO2004108761A2
(en)
*
|
2003-05-01 |
2004-12-16 |
Merial Limited |
Canine ghrh gene, polypeptides and methods of use
|
|
EP1571159A1
(en)
|
2004-03-04 |
2005-09-07 |
Bayerische Julius-Maximilians-Universität Würzburg |
Mutein of a bone morphogenetic protein and use thereof
|
|
JP2008500816A
(ja)
*
|
2004-03-31 |
2008-01-17 |
ゼンコー・インコーポレイテッド |
改善された性質を有するbmp−7変異体
|
|
US20100291173A1
(en)
|
2006-09-05 |
2010-11-18 |
Ed. Geistlich Soehne Ag Fuer Chemische Industrie |
Method of improving renal function
|